Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khemchand Rajendra Surana has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and Quality Evaluation of Betalain-Enriched Nutraceutical Capsules from Beta vulgaris

    by Vijayraj Sonawane, Diksha K. Sonawane, Khemchand R. Surana, Kalyani J. Sisodiya, Chetana K. Jadhav

    Introduction: Iron deficiency anemia, a common nutritional disease, affects health, productivity and quality of life. Conventional iron supplements often cause gastrointestinal adverse effects, leading to low patient compliance. Due to their improved tolerability and therapeutic benefits, plant-based nutraceuticals are popular. Beetroot is rich in iron and betalain pigments, which may promote erythropoiesis and reduce oxidative stress. Methods: Fresh beetroot tubers were processed to obtain powdered material, which was further extracted and analyzed using UV-visible spectrophotometry for estimation of betalain content and analytical characterization. Two capsule formulations were developed using direct filling and wet granulation techniques. The prepared formulations were evaluated for preformulation parameters such as flow properties and postformulation parameters including weight variation, disintegration time, assay, content uniformity and in vitro dissolution. All evaluations were carried out in accordance with pharmacopoeial standards. Results: Both formulations showed satisfactory physicochemical properties and complied with pharmacopoeial requirements. The prepared capsules exhibited good flow characteristics, uniform weight variation, rapid disintegration, and acceptable content uniformity. In vitro dissolution studies indicated effective drug release from both formulations, with the wet granulation method demonstrating slightly improved dissolution performance compared to the direct filling method. Conclusion: The developed Beta vulgaris-based herbal capsules demonstrated desirable quality attributes and met standard evaluation criteria. The findings indicate that the formulation may serve as a safe and effective nutraceutical option for improving iron levels and providing antioxidant support in the management of iron deficiency anemia.

  • Open Access

    Computer-Aided Drug Design: From Conventional Approaches to Artificial Intelligence and Machine Learning

    by Khemchand R. Surana, Gaurav N. Kasar, Tushar N. Lokhande

    Rapid advances in computational science, molecular biology, bioinformatics and artificial intelligence over the last few decades have significantly improved the way that the field of drug discovery is conducted. Traditional approaches to drug discovery, while important, are typically expensive, time consuming and have high attrition rates. To address these challenges Computer-Aided Drug Design (CADD) has been developed as a powerful tool and indispensable aid in the research and development of modern pharmaceutical industry which increases efficiency, decreases the expenditure and boosts the success rate of modern drug designing process. To give a detailed glimpse into the principles, approaches, applications, and recent advances in computational drug discovery, the book “Computer-Aided Drug Design: From Conventional Approaches to Artificial Intelligence and Machine Learning” is put together. It demonstrates and reviews the use of computational methods in the discovery, optimization, and design of therapeutic agents, including the ability to analyze large sets of complex biological data, to predict the interactions of molecules and molecular ensembles, or to design novel, more potent drug molecules with safer ADMET profiles. The themes covered by this book range from virtual screening to molecular docking, from pharmacophore modelling to quantitative structure–activity relationship (QSAR) studies and from homology modelling to the in silico toxicity assessment and beyond. Of particular interest are new computational technologies that are transforming the pharmaceutical sector and speeding the pace of moving science to the clinic. The main aim of this book is to make CADD more easily understood and related to practical application. It will be useful to undergraduate and postgraduate students, researchers, academicians, pharmaceutical scientists, medicinal chemists, bioinformaticians and professionals in the pharmaceutical/biotechnology sectors. This book will present the basic concepts as well as the latest advancements in computational methods that are applied to drug discovery. All chapters in this book have been meticulously arranged to provide a glimpse into the development of computer-aided drug design from the traditional computational approaches to the present-day tools and techniques in artificial intelligence. Many examples and case studies are included to illustrate its practical use of such techniques in finding new drug leads, particularly for different diseases. The book also covers ongoing issues and prospects in the field, with a focus on the increasing use of computation-based methods in precision medicine and personalized therapeutics. Hopefully, this volume will get readers to see the enormous potential of computer science applications to pharmaceutical sciences and will stimulate further research in this rapidly changing field. Incorporating computational intelligence in the context of biology and chemistry is continuing to spark new ideas for innovation, that will lead to more powerful, effective, and patient friendly medicines for people globally. Finally, we would like to thank all researchers, educators and scientists that have made pioneering contributions and set the stage to improve computer-aided drug design. Today, their work continues to influence the future of drug discovery and enhance health care efforts around the world. We hope that this book will be helpful for all who wish to follow this inevitably exciting and dynamic field of Computer-Aided Drug Design (CADDD).

  • Open Access

    Design of Cyclodextrin-Based Sustained Release Formulation of Benzbromarone: A Step toward Improved Management of Gout

    by Eknath D. Ahire, Sanket S. Pawar, Sanjay J. Kshirsagar, Rajendra T. Mogal, Khemchand R. Surana

    Introduction: The current study aimed to enhance the bioavailability of benzbromarone through the creation of a sustained-release (SR) tablet, employing β-cyclodextrin complexation to promote solubility and diminish protein binding. Benzbromarone is a uricosuric medication that works by blocking the URAT1 exchanger in the renal proximal tubule. It has low bioavailability since it doesn’t dissolve well in water and binds to proteins strongly. Methods: The drug-β-cyclodextrin complex was created and made into sustained-release tablets by mixing and matching varying amounts of HPMC K4M and HPMC K100M as matrix-forming polymers. The formulations were tested for pre- and post-compression characteristics, in vitro dissolution, and kinetic modeling. Results: Formulation F6, which had 10% total polymer concentration (5% HPMC K4M and 5% HPMC K100M), had the best physicochemical qualities and released the most medication for 24 hours (95.71%). Kinetic modeling showed that the release followed zero-order kinetics (R² = 0.9979) and was in line with the Higuchi diffusion model (R² = 0.9784), which points to a diffusion-controlled mechanism. Conclusion: The results show that β-cyclodextrin considerably improves the solubility and release properties of benzbromarone, making it a viable sustained-release formulation for better gout treatment.

  • Open Access

    A greener approach for the synthesis of Phenolic derivatives using Hydrogen Peroxide and Biomass-derived Ash Catalysts

    by Khemchand Surana, Pallavi Jadhav, Harshada Shewale, Dipa Wagh, Vijayraj Sonawane

    Green chemistry aims to develop environmentally benign chemical processes that minimize hazardous reagents and waste generation. In the present study, naturally derived ash extracts obtained from banana peel (AEBP), papaya peel (AEPP), pomegranate peel (AEPmP), and potato peel (AEPoP) were investigated as green catalytic media for the Dakin oxidation of substituted aromatic aldehydes using hydrogen peroxide as an oxidant. The reactions were carried out under mild conditions at room temperature using 30 % H₂O₂ in aqueous medium. Various substituted aldehydes were converted to the corresponding phenolic derivatives with reaction times of 40–60 min and yields ranging from 51.55 % to 98.40 %. Among the catalysts evaluated, AEPmP exhibited the highest catalytic activity, which may be attributed to the presence of alkaline mineral components such as potassium and sodium carbonates in the ash extract. The synthesized products were characterized by melting point determination, thin-layer chromatography, and UV–Visible spectroscopy. The developed protocol offers a simple, economical, and environmentally friendly alternative to conventional Dakin oxidation methods that require strong bases and organic solvents.

  • Open Access

    In silico design and evaluation of 2,4,5-trisubstituted Imidazoles as potential dual inhibitors of MAGL and COX-2

    by Khemchand Surana, Saurabh Gaikwad, Vinod Govekar, Punam Ahire

    This study investigates the design of 2, 4, 5-substituted imidazole molecules as potential inhibitors of monoacylglycerollipase (MAGL) and cyclooxygenase-2 (COX-2), key enzymes involved in inflammation. Using computational approaches, we explore their binding affinity, molecular interactions, and anti-inflammatory potential, aiming to identify promising drug candidates. The drug-target interactome can also be studied by in silico modeling. Drug repositioning has made use of molecular docking techniques to leverage the vast array of protein structures found in the Protein Data Bank (PDB). This investigation used the computer tool CB Dock to molecularly dock imidazole molecules with the selected proteins COX-2 (PDB ID: 5JVZ) and MAGL (PDB ID: 6BQ0). In this, the drug's possible toxicity and likelihood (Lipinski's rule of 5) were evaluated using the ProTox 2.0 software. Since the attributes of the design molecules fall within reasonable bounds, we may be certain that the design molecules follow Lipinski's rule of five. With docking scores ranging from -7.6 to -11.6 (MAGL) and -7.7 to -10.2 (COX-2), the suggested compounds demonstrated favorable pharmacokinetic features when compared to the reference ibuprofen. It was found that design molecule 3e exhibited the strongest affinity (docking score) of -11.6, whereas compounds 3c, 3j, and 3p exhibited the strongest affinity of -10.2 for the COX-2 (PDB ID: 5JVZ) receptor and can be considered as hit compounds for further studies.

  • Open Access

    Computational Drug Design and Development: Artificial Intelligence, Molecular Modeling, and Structure-Based Discovery

    by Khemchand R. Surana, Gaurav N. Kasar, Sunil K. Mahajan

    For us editors, writing “Computational Drug Design and Development: Artificial Intelligence, Molecular Modeling, and Structure-Based Discovery” has been an interesting and educational experience. We have seen the quick development of computational tools in the pharmaceutical sciences over time. What was formerly thought of as a specialized method is now a crucial component of research and drug development. We have attempted to convey these developments in a way that is understandable, useful, and significant for scholars, professionals, and students in this book. The groundwork is laid in the first chapter, Novel Techniques of Drug Design and Development, which outlines the fundamentals of contemporary computational drug design. It makes a distinction between structure-based and ligand-based methods and considers how machine learning and artificial intelligence are progressively shortening development times while increasing forecast accuracy. Pharmacophores are covered in detail in the second chapter, Pharmacophore-Based Drug Design and Drug Delivery. The chapter describes how software tools such as MOE and LigandScout help find important chemical interactions and direct drug delivery tactics, as well as how three-dimensional pharmacophore models are constructed. Drug Metabolism and Pharmacokinetics (DMPK) Profiling is the main subject of Chapter 3. Here, we have highlighted the importance of in-silico ADME prediction using tools like Simcyp and GastroPlus, particularly in safety and regulatory assessments. The focus of the fourth chapter, Drug Design Approaches for Biotechnology, is on biologics, including proteins, peptides, and monoclonal antibodies. This chapter discusses how computational techniques are being applied to solve problems with stability, delivery, and immune response in the design of biologics. The use of QSAR models to improve predictive reliability is presented in chapter five, The Concept of Pharmacophore Mapping, along with techniques for virtual screening, hit detection, and lead optimization. An overview of popular computational programs, such as AutoDock, GOLD, GROMACS, AMBER, SwissADME, and pkCSM, is given in Chapter 6. Since these are particularly helpful for academic and laboratory learning, we have also included widely used open-source software. Toxicity Prediction by Computational Software is covered in Chapter 7. Early prediction using tools like VEGA QSAR, TOPKAT, and Derek Nexus can greatly lower risks throughout development because toxicity is still a key reason of drug withdrawal. We hope that the case studies, comparison tables, and workflow diagrams in the final section will aid in practical comprehension. We also provide a brief overview of how artificial intelligence will influence drug creation in the future. We sincerely hope that this book proves helpful to its readers. If it encourages curiosity or sparks new research ideas, we will consider our effort worthwhile.

  • Open Access

    In silico prediction of some indole derivatives against virb8 from Brucella suis and cyanobacterial membrane-bound manganese superoxide dismutase

    by Khemchand Surana, Srushti Jadhav, Renuka Khairnar, Eknath Ahire, Gaurav Kasar

    This study investigates green chemistry methods to design the indole derivatives with potential medicinal properties. When benzaldehyde compounds react with phenyl hydrazine and ortho-phosphoric acid in an acidic environment, synthesized the indole derivatives. There are two proteins chosen from the protein data bank: the crystal structure of VirB8 from Brucella suis (PDB ID: 2BHM) for evaluation of antibacterial potential and a type of manganese superoxide dismutase (MnSOD) from cyanobacteria (PDB ID: 1GV3) for antioxidant potential. The molecule 3g had the best docking score of -10.4 with the crystal structure of VirB8 from Brucella suis (PDB ID 2BHM), which means it has a strong ability to bind to the target receptor. The molecule 3j had the best docking score of -10.4 against manganese superoxide dismutase (MnSOD) in the membrane of cyanobacteria (PDB ID: 1GV3), showing that it strongly attaches to the target receptor. The result suggests that it has a strong affinity for binding to the target receptor. This result indicates that it has a strong affinity for the target receptor. The metronidazole is taken as a standard for comparison purposes and has a molecular docking score of -6.5 against the crystal structure of VirB8 from Brucella suis. Ascorbic acid is used as a standard. It has a molecular docking score of -5.7 against manganese superoxide dismutase (MnSOD), which is attached to the membrane of cyanobacteria. The remaining design molecules demonstrated excellent docking scores for both proteins when compared to the standard molecules, metronidazole and ascorbic acid. In this study, ProtTox II Software was used to predict the in silico toxicity of all the design molecules. It was found that molecules 3l and metronidazole were respiratory toxic, while compounds 3g, 3k, 3p, and 3r were neurotoxic. All designed molecules were screened for the drug-likeness property and obeyed the criteria of the Lipinski rule of five.


  • Open Access

    Development and Validation of a Robust RP-HPLC Method for the Estimation of Remogliflozin Etabonate in Bulk and Tablet Dosage Forms

    by Kiran Prakash Surywanshi, Shivraj Popat Jadhav, Khemchand Rajendra Surana, Parag Ashok Pathade, Sunil Kashinath Mahajan

    Remogliflozin etabonate, a selective inhibitor of SGLT2, is prescribed for managing type 2 diabetes mellitus. To support quality control and routine testing, a dependable and efficient analytical technique is essential. The present study consists of a rapid, precise, and straightforward Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) method development for quantifying remogliflozin etabonate. An Inertsil ODS-3V column (150*4.6 mm, 5 µm) was used for separation. Optimization of the mobile phase was done from methanol: water (70:30, v/v) to acetonitrile: water (75:25, v/v), flow rate of 1.0 mL/min, and samples were analysed at 230 nm using a UV detector. ICH Q2(R1) was followed for validation of the method to assess various parameters like linearity, accuracy, precision, robustness, LOD, and LOQ. The assay demonstrated excellent linearity over 10–50 µg/mL (R² = 0.999), with a retention time of 2.55 min. Precision results showed %RSD values below 2%, while recovery studies confirmed accuracy within 98–102%. The calculated LOD and LOQ were 0.22 µg/mL and 0.68 µg/mL, respectively. The validated technique proved to be simple and robust, with adequate specificity, and can be effectively applied for routine analysis of remogliflozin etabonate in bulk as well as pharmaceuticals.


  • Open Access

    Una síntesis ecológica de catecol en H2O2 mediante el uso de catalizadores preparados naturalmente: WEWSA y WECMA

    by Khemchand Surana, Sagar Bhawar, Sunil Mahajan, Deepak Sonawane

    Introducción: La química verde proporciona un marco para desarrollar procesos y productos químicos innovadores. Estas directrices abarcan todos los aspectos del ciclo de vida de un proceso, incluyendo las materias primas utilizadas, la eficacia y seguridad de la transformación, y la toxicidad y biodegradabilidad de los productos y reactivos empleados. Métodos: El uso de la reacción de Dakin de una manera menos dañina para el medio ambiente fue la inspiración para nuestro novedoso enfoque para la producción de catecol. Los arilaldehídos aromáticos pueden transformarse en fenoles a temperatura ambiente con la ayuda de H₂O₂-WEWSA y WECMA. Resultados: El sistema catalítico debería funcionar idealmente sin necesidad de activación o presencia de catalizadores de metales de transición, ligandos tóxicos, aditivos/promotores, bases, disolventes orgánicos o sustancias similares. Conclusión: Para evaluar la eficacia de este método, se examinaron varios benzaldehídos hidroxilados sustituidos.


  • Open Access

    Development and Evaluation of Moisturizing Cream containing Salvia hispanica and Aloe vera and its Antioxidant Potential

    by Rutuja K. Deore, Khemchand Surana, Sunil K. Mahajan, Rushikesh L. Bachhav, Deepak D. Sonawane

    Introduction: Bioactive chemicals in Salvia hispanica (Chia) seeds and Aloe vera hydrate, protect, and restore skin. The goal of this work will formulate and evaluate a multifunctional herbal cream with Salvia hispanica seed mucilage, Aloe vera gel, shea butter, and coconut oil to hydrate and restore skin. Methods: Salvia hispanica seed extract was obtained through mucilage extraction. Aloe vera gel was prepared and incorporated into the formulation along with shea butter and coconut oil. The final cream formulation was evaluated for physicochemical parameters such as pH (6), spreadability (7.5 g/sec), consistency, washability, and non-irritancy. The hydrogen peroxide scavenging assay for antioxidant activity performed. Results: The formulated cream demonstrated antioxidant activity revealed a significant hydrogen peroxide scavenging activity of 95.16 %, indicating high radical scavenging potential. The formulation exhibited desirable physicochemical characteristics. Conclusion: This study found that the cream is antioxidant activity with its natural composition and helpful plant-based components; it could be an effective and sustainable skincare solution.